Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA host gene 11 (SNHG11) is a long non-coding RNA (lncRNA) that does not encode a protein but plays significant regulatory roles in gene expression, chromatin remodeling, and post-transcriptional regulation through interactions with DNA, RNA, and proteins. It hosts two small nucleolar RNAs within its introns and is predominantly localized to the nucleus, especially in cancer cells. SNHG11 is upregulated in various human cancers (including colorectal, lung, and triple-negative breast cancer) and has been shown to promote tumor cell proliferation, migration, invasion, and resistance to apoptosis, in part via interaction with HIF-1α and as a competing endogenous RNA for various microRNAs. Due to its dysregulation in disease states and role in modulating critical disease pathways, it is under study as both a biomarker and a potential therapeutic target in oncology and inflammatory disease settings. No approved drugs currently target SNHG11 directly, but its mechanisms involve epigenetic regulation, microRNA interaction, and stabilization of oncogenic protein partners.
SNHG11 acts as a scaffold or guide RNA to interact with and stabilize protein partners (e.g., HIF-1α), preventing their degradation and supporting transcription of oncogenic genes under hypoxia. Functions as a ceRNA to sponge various miRNAs, thereby derepressing target oncogenes. Modifies chromatin state to regulate expression of genes involved in cell proliferation and differentiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA host gene 11 (SNHG11).